Search Results - Oral Alpan
- Showing 1 - 5 results of 5
-
1
-
2
Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease. by Renuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, Mark Ryherd, Lina Kozhaya, Lauren Austin, Cem Abidoglu, Derya Unutmaz, Oral Alpan, Ozlem Goker-Alpan
Published in PLoS ONE (2016-01-01)Get full text
Article -
3
Enhancing allergy diagnosis: mass spectrometry as a complementary technique to the basophil activation test by Nicole Wheeler, Miloslav Sanda, Lanya Rasool, Noha Elemary, Arda Alpan, Hamed Safi, Denise Loizou, Matthew Plassmeyer, Mikell Paige, Mikell Paige, Soren Ulrik Sonder, Oral Alpan, Michael Girgis, Michael Girgis
Published in Frontiers in Allergy (2025-05-01)Get full text
Article -
4
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS) by Stanley J. Szefler, Graham Roberts, Adalberto S. Rubin, Stefan Zielen, Piotr Kuna, Oral Alpan, Judith Anzures‐Cabrera, Qiang Chen, Cécile T. J. Holweg, Janusz Kaminski, Wendy S. Putnam, John G. Matthews, Nikhil Kamath
Published in Clinical and Translational Allergy (2022-07-01)Get full text
Article -
5
Towards an FDA-cleared basophil activation test by Oral Alpan, Richard L. Wasserman, Theodore Kim, Amy Darter, Atul Shah, Douglas Jones, Donald McNeil, Henry Li, Laura Ispas, Melinda Rathkopf, Elena Perez, Dareen Siri, Maeve O’Connor, Matthew Plassmeyer, Kimberly Romito, Christina Pettibone, Sean O’Reilly, Søren Ulrik Sønder, Gerald Marti
Published in Frontiers in Allergy (2023-01-01)Get full text
Article
